Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:37 am Purchase | 2022-12-31 | 13G | Immunovant, Inc. IMVT | Deep Track Capital, LP | 9,710,000 7.520% | 2,929,173 (+43.20%) | Filing History |
| 2023-02-14 08:36 am Unchanged | 2022-12-31 | 13G | Immunic, Inc. IMUX | Deep Track Capital, LP | 4,022,989 8.320% | 0 (Unchanged) | Filing History |
| 2023-02-14 08:35 am Sale | 2022-12-31 | 13G | HOOKIPA Pharma Inc. HOOK | Deep Track Capital, LP | 124,037 2.370% | -379,563 (-75.37%) | Filing History |
| 2023-02-14 08:34 am Sale | 2022-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | Deep Track Capital, LP | 0 0.000% | -3,646,690 (Position Closed) | Filing History |
| 2023-02-14 08:34 am Sale | 2022-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Deep Track Capital, LP | 0 0.000% | -2,686,655 (Position Closed) | Filing History |
| 2023-02-14 08:32 am Purchase | 2022-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 2,656,901 8.200% | 756,901 (+39.84%) | Filing History |
| 2023-02-14 08:32 am Sale | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital, LP | 2,684,200 5.150% | -132,750 (-4.71%) | Filing History |
| 2023-02-14 08:31 am Purchase | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital, LP | 2,819,045 9.500% | 1,322,907 (+88.42%) | Filing History |
| 2023-02-14 08:30 am Unchanged | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 15,000,000 8.670% | 0 (Unchanged) | Filing History |
| 2023-02-14 08:29 am Sale | 2022-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH | Deep Track Capital, LP | 324,238 0.230% | -7,517,332 (-95.87%) | Filing History |
| 2023-02-14 08:27 am Unchanged | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Deep Track Capital, LP | 1,816,531 6.610% | 0 (Unchanged) | Filing History |
| 2023-02-14 08:26 am Sale | 2022-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Deep Track Capital, LP | 152,786 3.760% | -97,214 (-38.89%) | Filing History |
| 2023-02-14 08:25 am Sale | 2022-12-31 | 13G | Ardelyx, Inc. ARDX | Deep Track Capital, LP | 0 0.000% | -14,252,831 (Position Closed) | Filing History |
| 2023-02-14 08:24 am Purchase | 2022-12-31 | 13G | Allakos Inc. ALLK | Deep Track Capital, LP | 4,899,179 5.750% | 380,604 (+8.42%) | Filing History |
| 2023-02-14 08:23 am Purchase | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | Deep Track Capital, LP | 1,704,000 8.230% | 579,579 (+51.54%) | Filing History |
| 2023-02-14 08:23 am Purchase | 2022-12-31 | 13G | Agenus Inc. AGEN | Deep Track Capital, LP | 1,375,650 8.860% | 599,723 (+77.29%) | Filing History |
| 2023-02-14 08:21 am Purchase | 2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Deep Track Capital, LP | 3,952,000 9.660% | 1,537,083 (+63.65%) | Filing History |
| 2023-02-03 4:31 pm Purchase | 2023-02-03 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital, LP | 7,940,346 7.610% | 7,940,346 (New Position) | Filing History |
| 2023-01-13 4:14 pm Purchase | 2023-01-06 | 13G | Geron Corporation GERN | Deep Track Capital, LP | 24,022,883 5.350% | 24,022,883 (New Position) | Filing History |
| 2022-12-22 4:02 pm Purchase | 2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS | Deep Track Capital, LP | 1,816,531 7.320% | 1,816,531 (New Position) | Filing History |